Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence.
Rajkumar
S Vincent
SV
Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. rajkumar.vincent@mayo.edu
Kyle
Robert A
RA
Buadi
Francis K
FK
D003584:Cytological Techniques / Q000379:methods; D003937:Diagnosis, Differential; D018450:Disease Progression; D014943:Global Health; D006801:Humans; D009017:Morbidity / Q000639:trends; D010265:Paraproteinemias / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology; D011230:Precancerous Conditions; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends